The most talked‑about saga of this summer's transfer window unfolded on the final day of business, entangling three clubs and two high‑profile players in a tangled web of negotiations, medical concerns and last‑minute reversals. Chelsea, Everton and Monaco all walked away from the window feeling short‑changed after Folarin Balogin chose to abandon a move to Everton at the eleventh hour, while Monaco simultaneously withdrew from a separate deal that would have seen them sell midfielder Lamine Camara to Chelsea as a replacement for the departing Enzo Fernandez. Both Premier League sides were left fuming, and the drama surrounding the collapsed agreements offers a textbook example of how quickly a deadline‑day bargain can implode when medical reports, financial tweaks and competing interests collide. Sky Sports News has pieced together the chain of events that turned what seemed a straightforward £40 million transfer for Balogun into a chaotic, multi‑club fallout.
Monaco entered the market needing cash to ease a mounting debt problem, while Everton were desperate to add a proven Premier League striker to a thin attacking line‑up that had already seen the sale of Beto to Fiorentina for £15.4 million. Balogun, a talented U.S.
international who had impressed with his pace and finishing at Arsenal, appeared to be the perfect solution for both parties. After weeks of negotiation, the clubs announced a £40 million agreement, and it seemed the deal was set to be sealed. The first snag emerged during Everton's medical examination. The club's doctors flagged a potential injury, prompting a dispute: Monaco and the player himself insisted Balogun was fully fit and could feature immediately, while Everton's medical staff remained unconvinced.
With the transfer deadline looming, Everton faced a dilemma – proceed with the deal as originally structured, or renegotiate to protect themselves against the risk of an unfit player. Choosing the latter, Everton opted to keep the transfer fee but reshape the payment schedule, inserting performance‑related clauses that would reduce Monaco's payout if Balogun failed to make a set number of appearances. Importantly, Balogun's personal terms – salary, bonuses and contract length – were reportedly left untouched, meaning his own compensation remained unchanged despite the club‑to‑club adjustments.
At roughly the same time, Chelsea were finalising their own business with Monaco. With Enzo Fernandez set to join Manchester City in a joint‑British record £125 million transfer, the Blues needed a creative midfielder to fill the void. They identified Lamine Camara as a suitable candidate and reached an agreement with Monaco to bring him to Stamford Bridge. Everton, meanwhile, made a separate push for Manchester United forward Joshua Zirkzee, offering a loan deal that included a total package of around £10 million covering wages and a loan fee.
The proposal was turned down by United, who felt the offer arrived too late and did not match the player's valuation. This rejection, however, had unintended consequences. According to reports, the Toffees' pursuit of Zirkzee was perceived by Balogun as a sign that Everton were looking beyond him, potentially signing another striker behind his back.
Balogun's frustration became public when Monaco chief Thiago Scuro relayed the player's comments at a press conference. Balogun alleged that Everton's medical department had cast doubt on his health, leaving him feeling unwelcome and unwilling to commit to a long‑term contract with a club that seemed to question his fitness. He insisted there was no medical issue, but the perceived lack of confidence from Everton's staff was enough to make him walk away.
Everton, for their part, denied any intention to make Balogun feel unwanted. They maintained that they never altered his personal terms and that the renegotiated club‑to‑club fee was a prudent response to the medical uncertainty, not a sign of disrespect. The club also clarified that their interest in Zirkzee was independent of the Balogun saga; they had hoped to bolster the attack with both players, not replace one with the other. The fallout was swift.
Monaco, having been forced to choose between selling Balogun or Camara, decided to keep both players after the Chelsea deal fell through. The Ligue 1 side preferred a single, larger sale to address their financial needs, and when Balogun withdrew, they reverted to retaining Camara as well. Everton, left without a new striker, were forced to rely on the modest options of Thierno Barry and other fringe forwards after the departure of Beto. Their transfer window effectively closed with a glaring gap in attacking firepower, a situation that could hamper their Premier League campaign.
Chelsea, on the other hand, entered the season without a direct replacement for Fernandez. Although they honoured the deal that sent Fernandez to City, they were left to scramble for alternatives, ultimately turning to existing squad depth and later signings to fill the creative midfield role. In the weeks that followed, speculation grew about whether any of the deals could be resurrected in the January window. Given the bruised relationships and the public nature of the disputes, a revival appears unlikely.
The three clubs now must move forward, each having missed out on their primary targets and facing the challenge of reshaping their squads mid‑season. The Balogun episode serves as a cautionary tale about the fragility of deadline‑day deals, the impact of medical opinions, and the importance of clear communication between clubs and players. It also highlights how a single player's perception of treatment can ripple outward, affecting multiple transfer strategies and leaving clubs to pick up the pieces after a chaotic close to the summer market.